These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2522499)

  • 1. The generation of antigen-specific, major histocompatibility complex-restricted cytotoxic T lymphocytes of the CD4+ phenotype. Enhancement by the cutaneous administration of interleukin 2.
    Hancock GE; Cohn ZA; Kaplan G
    J Exp Med; 1989 Mar; 169(3):909-19. PubMed ID: 2522499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.
    Kaplan G; Kiessling R; Teklemariam S; Hancock G; Sheftel G; Job CK; Converse P; Ottenhoff TH; Becx-Bleumink M; Dietz M
    J Exp Med; 1989 Mar; 169(3):893-907. PubMed ID: 2494293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterial-induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients.
    Kaleab B; Ottenoff T; Converse P; Halapi E; Tadesse G; Rottenberg M; Kiessling R
    Eur J Immunol; 1990 Dec; 20(12):2651-9. PubMed ID: 2269329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients.
    de la Barrera S; Finiasz DM; Fink S; Valdez R; Bottasso O; Balina LM; Sasiain MC
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):45-55. PubMed ID: 9207753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the mechanism of human T cell suppression.
    Salgame P; Modlin R; Bloom BR
    Int Immunol; 1989; 1(2):121-9. PubMed ID: 2535060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of antigen-specific CD4+ HLA-DR-restricted cytotoxic T lymphocytes as well as nonspecific nonrestricted killer cells by the recombinant mycobacterial 65-kDa heat-shock protein.
    Ab BK; Kiessling R; Van Embden JD; Thole JE; Kumararatne DS; Pisa P; Wondimu A; Ottenhoff TH
    Eur J Immunol; 1990 Feb; 20(2):369-77. PubMed ID: 1690136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy.
    Shankar P; Agis F; Wallach D; Flageul B; Cottenot F; Augier J; Bach MA
    J Immunol; 1986 Jun; 136(11):4255-63. PubMed ID: 2422278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major histocompatibility complex-unrestricted cytolytic activity of human T cells. Analysis of precursor frequency and effector phenotype.
    Patel SS; Thiele DL; Lipsky PE
    J Immunol; 1987 Dec; 139(11):3886-95. PubMed ID: 3500232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.
    McMenamin C; Holt PG
    J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic human HLA class II restricted purified protein derivative-reactive T-lymphocyte clones. IV. Analysis of HLA restriction pattern and mycobacterial antigen specificity.
    Hansen PW; Petersen CM; Povlsen JV; Kristensen T
    Scand J Immunol; 1987 Mar; 25(3):295-303. PubMed ID: 3494302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic, functional, and molecular genetic studies of human natural killer cells and cytotoxic T lymphocytes not restricted by the major histocompatibility complex.
    Lanier LL; Le AM; Cwirla S; Federspiel N; Phillips JH
    Fed Proc; 1986 Nov; 45(12):2823-8. PubMed ID: 3095151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study on the effects of rIL-4, rIL-2, rIFN-gamma, and rTNF-alpha on specific T-cell non-responsiveness to mycobacterial antigens in lepromatous leprosy patients in vitro.
    Ottenhoff TH; Wondimu A; Reddy NN
    Scand J Immunol; 1990 May; 31(5):553-65. PubMed ID: 2111939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquisition of non-MHC restricted cytotoxic function by IL 2 activated thymocytes with an "immature" antigenic phenotype.
    Phillips JH; Lanier LL
    J Immunol; 1987 Aug; 139(3):683-7. PubMed ID: 3110279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy.
    Kaplan G; Britton WJ; Hancock GE; Theuvenet WJ; Smith KA; Job CK; Roche PW; Molloy A; Burkhardt R; Barker J
    J Exp Med; 1991 Apr; 173(4):993-1006. PubMed ID: 2007862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
    Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific lysis by CD8+ T cells of Schwann cells expressing Mycobacterium leprae antigens.
    Steinhoff U; Kaufmann SH
    Eur J Immunol; 1988 Jun; 18(6):969-72. PubMed ID: 2454827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intradermal recombinant interleukin 2 enhances peripheral blood T-cell responses to mitogen and antigens in patients with lepromatous leprosy.
    Converse P; Ottenhoff TH; Work Teklemariam S; Hancock GE; Dietz M; Becx-Bleumink M; Wondimu A; Kiessling R; Cohn ZA; Kaplan G
    Scand J Immunol; 1990 Aug; 32(2):83-91. PubMed ID: 2389115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine CD8+ T suppressors against mycobacterial 65-kDa antigen compete for IL-2 and show lack of major histocompatibility complex-imposed restriction specificity in antigen recognition.
    Khetan S; Sainis KB; Rath S; Kamat R
    Eur J Immunol; 1993 Oct; 23(10):2440-7. PubMed ID: 8405043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.